PCN115 COMPARISON OF ADVERSE EVENT COSTS OF...

PCN115 COMPARISON OF ADVERSE EVENT COSTS OF NIVOLUMAB+IPILIMUMAB VERSUS SUNITINIB FOR PREVIOUSLY UNTREATED INTERMEDIATE-/POOR-RISK ADVANCED RENAL CELL CARCINOMA IN SPAIN

Polanco Sánchez, C., Gooden, K.M., May, J., Malcolm, B., Du, E.X., Yin, L., Betts, K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.312
Date:
November, 2019
File:
PDF, 382 KB
2019
Conversion to is in progress
Conversion to is failed